STEVEN GILMAN

Plain English
The research looked at how to turn health data into useful knowledge to improve healthcare continuously. It identified important areas, tools, and actions needed to create a learning health system, which enhances patient care over time. This matters because better systems for using health information can lead to smarter healthcare decisions and improved outcomes for patients. Who this helps: Patients and healthcare providers.

Plain English
This study looked at two methods used to prepare obese women for vaginal delivery: a cervical ripening balloon and a vaginal insert called dinoprostone. It found that while both methods resulted in similar rates of vaginal delivery (about 80% for the balloon and about 68% for the insert), the dinoprostone insert was linked to a higher rate of health problems in newborns (39.3% compared to 18.7% for the balloon). This matters because it highlights that using the balloon may be safer for the babies of obese women who need cervical ripening. Who this helps: Obese pregnant women and their babies.

Plain English
This study looked at online self-management education programs for people with lupus and other chronic conditions to see how effective they are and where improvements are needed. Out of nearly 2,000 articles reviewed, only 16 met the criteria, highlighting that there is currently only one program specifically for lupus, while most others focused on conditions like epilepsy and multiple sclerosis. The findings show that most programs helped improve symptoms, indicating that digital education can be beneficial for managing chronic health issues. Who this helps: Patients with lupus and their healthcare providers.

Plain English
This study looked at how stress and depression experienced by mothers during pregnancy affect their children's behavior and mental health. Researchers found that higher maternal depression was linked to more psychiatric issues and lower cognitive skills in children, especially in boys, but prenatal stress did not significantly impact fetal growth. Understanding these connections is important because even minor prenatal stress may have lasting effects on a child's well-being. Who this helps: This information benefits parents and healthcare providers by highlighting the importance of maternal mental health during pregnancy.

Plain English
This study looked at how effective phone counselling is for helping people quit smoking when they are part of a lung cancer screening program. Researchers found that only 12% of those referred by the lung cancer screening program quit smoking after six months, which is much lower than those referred by healthcare workers, who had a quit rate of 26%. This highlights the need for better, personalized support for those in lung cancer screening programs to help them successfully quit smoking. Who this helps: Patients at risk of lung cancer who need support to quit smoking.

Plain English
This study looked at how serotonin transporters in the brain are affected in patients with multiple system atrophy (MSA) compared to those with Parkinson's disease (PD). Researchers scanned 18 MSA patients, 23 PD patients, and 16 healthy controls, finding that MSA patients had significantly lower serotonin transporter levels in several brain areas compared to PD patients. This matters because a better understanding of serotonin's role in MSA could help identify specific motor impairments unique to this condition. Who this helps: This benefits patients with multiple system atrophy and their doctors by providing insights into their condition.

Plain English
This study focused on a protein called claudin 6 (CLDN6), which is found on cancer cells but not in healthy tissue, making it a good target for treatment. The researchers developed new antibodies that specifically bind to CLDN6 without reacting to a similar protein, claudin 9 (CLDN9), and found that these antibodies can attach to CLDN6 more effectively than existing options. This matters because it may lead to more effective treatments for cancer patients with fewer side effects. Who this helps: This helps cancer patients by potentially providing more targeted therapies.

Plain English
This study looked at how certain groups, specifically Ultra-Orthodox Jewish communities and people in China, have been blamed for the spread of COVID-19. It found that while some accusations were unfair, there were also valid concerns about how specific behaviors in these communities contributed to the outbreak. Understanding this helps address the harm of false blame while acknowledging real issues related to public health. Who this helps: This helps public health officials, communities, and policymakers in addressing blame while promoting responsible health practices.

Plain English
The study looked at how an education program, called the VA Quality Scholars (VAQS), helped healthcare professionals learn to work better together to improve patient care. Researchers surveyed 102 graduates from the program, and they found that 70% of respondents used teamwork skills in their careers, with many noting a significant improvement in these skills after going through the program. This matters because better collaboration among healthcare providers can lead to improved patient safety and care quality. Who this helps: This helps healthcare professionals and patients by improving teamwork in medical settings.

Plain English
This study looked at the long-term effects of a training program called MAP-IT that helps doctors and nurses improve their mentoring and humanistic skills. Researchers spoke with 21 participants who completed the program between 2014 and 2016, and they found that the skills learned were still valuable years later, influencing areas like teamwork, conflict resolution, and professional behavior. This matters because it shows that investing in faculty development can lead to lasting changes that benefit both healthcare professionals and their patients. Who this helps: This helps doctors, nurses, and ultimately patients by improving the quality of care.

Plain English
This study looked at how online training helps NHS staff improve their skills in guiding patients to make healthier lifestyle choices, like quitting smoking or eating better. The training showed positive results, with eight key skills related to behavior change improving significantly after the training; for example, staff's confidence and knowledge increased (effect sizes of 0.27 to 0.51). This matters because better trained staff can lead to more effective conversations and support for patients, ultimately promoting better health outcomes. Who this helps: This helps healthcare staff and their patients seeking guidance on healthy behaviors.

Plain English
This research focused on creating a new tool to help doctors in the ICU keep track of vital patient information, especially during the pandemic. The tool successfully collected data on 57 different patient factors, making it easier for medical teams to access and share critical information. This is important because it can improve care for critically ill patients and can be customized for different doctors' needs, even in low-income areas where healthcare resources may be limited. Who this helps: This helps doctors and healthcare providers in the ICU, especially those in challenging settings.

Plain English
This study looked at how a program that trains healthcare workers together (like doctors, nurses, and pharmacists) affects the quality of care patients receive. It found that patients with diabetes had a 4.6% decrease in poor blood sugar control, more regular kidney tests, and older patients had a 2.3% reduction in prescriptions for risky medications. These improvements are significant because they can lead to better health outcomes for patients, reducing the chances of complications and hospital visits. Who this helps: Patients, especially those with diabetes and older adults, benefit from better coordinated care.

Plain English
This study examined how the nerves in the heart are affected over two years in patients with idiopathic Parkinson's disease (IPD). Researchers performed specialized heart scans on 39 IPD patients and found that 60.9% experienced worsening nerve function, with an average decline of 4.6% per year. This matters because it helps us understand the progression of heart issues in Parkinson’s patients, which can be crucial for managing their overall health. Who this helps: Patients with Parkinson's disease and their doctors.

Plain English
This paper looks at how preparing cancer patients for surgery—through physical, nutritional, and psychological support—can improve their care. The expert panel highlighted the need for more research on how this "surgical prehabilitation" can help patients recover faster, lower medical complications, and reduce overall healthcare costs. Their findings underscore the importance of improving patients' health before surgery to potentially lead to better outcomes. Who this helps: Patients preparing for cancer surgery.

Plain English
This study looked at how problems with the autonomic nervous system are linked to fatigue in people with Parkinson's disease. Researchers examined 29 patients and found a strong connection: those with more severe autonomic symptoms scored higher on the fatigue scale. Specifically, the study noted that issues like orthostatic intolerance were particularly tied to feelings of fatigue, with a significant relationship showing that more severe autonomic dysfunction correlated with higher fatigue levels. Who this helps: This helps patients with Parkinson's disease by highlighting the importance of managing autonomic symptoms to reduce fatigue.

Plain English
This study looked at whether rasagiline, a medication, could help people with a specific type of multiple system atrophy related to Parkinson's disease. After nearly a year, the results showed that those taking rasagiline experienced a slight decrease in symptoms, but the difference compared to those taking a placebo was not significant (an average of 7.2 versus 7.8 on a scale measuring their symptoms). Additionally, many participants experienced side effects, but the treatment did not seem to offer any real benefits for symptom management. Who this helps: This study helps doctors understand that rasagiline is not an effective treatment for this condition, guiding better care for patients.

Plain English
This research paper studied the Patient-Centered Medical Home (PCMH) model, which aims to improve patient care by ensuring that patients receive the right treatment from the right healthcare professionals at the right time and place. The findings highlighted that while there have been some successes in training healthcare workers to use this model, there are still significant challenges that need to be addressed, such as redefining primary care and reforming how healthcare is funded. Improving the PCMH model is important for enhancing the quality of care and addressing health disparities among different populations. Who this helps: This benefits patients, healthcare providers, and policymakers.

Plain English
This study looked at genetic variations in the GBA gene, which are known to cause Gaucher disease, and their connection to multiple system atrophy (MSA), a type of neurological disorder. Researchers analyzed 969 MSA patients and compared them to 1509 control subjects, finding that those with MSA had higher rates of these GBA variants. Specifically, the odds of having GBA variants were more than double in MSA patients compared to controls, showing a strong link between these genetic factors and MSA, especially in its cerebellar subtype. Who this helps: This research benefits patients with multiple system atrophy and their doctors by providing insights into genetic risk factors for the disease.

Plain English
This study looked at multiple system atrophy (MSA), a rare and severe brain disorder affecting movement and body functions, in the U.S. Researchers followed 175 patients for five years and found that the average time from when symptoms started to death was about 9.8 years. Patients who had severe autonomic issues at diagnosis lived an average of 8 years, while those without these severe symptoms lived about 10.3 years, highlighting the importance of early diagnosis and symptom management. Who this helps: This information benefits patients with multiple system atrophy and their doctors by providing insights on prognosis and the impact of symptoms on survival.

Plain English
This study looked at whether rifampicin, an antibiotic, could slow the progression of multiple system atrophy, a serious neurological disease. Over a year, 100 participants were divided into two groups—one received rifampicin and the other a placebo. The findings showed that rifampicin did not make a difference, with both groups experiencing similar declines in health (0.5 points per month), indicating it does not help with this disease. Who this helps: This information is important for doctors and researchers working on new treatments for multiple system atrophy.

Plain English
This study looked at how imaging techniques can help identify early signs of dementia in people with mild cognitive impairment (MCI). Researchers followed 27 MCI patients for about three years and found that 18 of them developed dementia during that time. They discovered that imaging methods showing amyloid buildup in the brain and dopamine loss strongly predicted who would progress to dementia, which means these techniques could be valuable tools for doctors in assessing and managing patients at risk. Who this helps: This helps patients with mild cognitive impairment and their doctors.

Plain English
This study looked at how a cellular response called the "unfolded protein response" (UPR) is activated in the brains of people with progressive supranuclear palsy (PSP) and Alzheimer's disease (AD). The researchers found that this response is mainly active in parts of the brain affected by these diseases, with significant activation in the pons and medulla for PSP and in the hippocampus for AD. They also found a genetic link that suggests higher activation of the UPR increases the risk of developing PSP rather than protecting against it. Who this helps: Patients with neurodegenerative diseases and their doctors.

Plain English
This study looked at 29 patients with multiple system atrophy (MSA), a progressive brain disorder that affects movement and autonomic functions, to see how well autonomic tests reflect the disease post-mortem. Researchers found that patients had severe issues with autonomic functions, indicated by a high Composite Autonomic Severity Score (average of 7.2 out of 10) and poor sweating response in 82% of cases. These findings matter because they confirm that certain clinical features and autonomic test results are strong indicators of MSA, which can improve diagnosis and care strategies. Who this helps: This helps patients and doctors by providing clearer criteria for diagnosing MSA.

Plain English
This research looked at a fellowship program started by the Veterans Affairs (VA) in 1998 aimed at training healthcare leaders in quality and safety. Since its inception, 106 alumni have actively contributed to the healthcare system, and recent cohorts have achieved impressive results, including five advanced degrees, 42 improvement projects, and 36 publications. This program is important because it creates skilled leaders who can enhance patient care and safety across the country. Who this helps: Patients and healthcare professionals.

Plain English
This study looked at changes in the brain's cholinergic system in people with Parkinson's disease (PD) who do not have dementia. Out of 101 PD participants, 36% showed lower activity in brain areas related to cholinergic function, which is linked to worse cognitive performance compared to those with normal activity levels. This research highlights the complex nature of Parkinson's disease and how specific brain changes can impact patients' cognitive abilities. Who this helps: This helps patients with Parkinson's disease and their doctors in understanding cognitive challenges related to the disease.

Plain English
This study explored the genes related to late-onset Alzheimer disease (LOAD) by looking for new genetic variations that might affect how genes are expressed in the brain. Researchers found that certain genetic variants, specifically CLU rs11136000 and MS4A4A rs2304933/rs2304935, significantly increase the expression levels of related genes in brain tissue from almost 400 subjects, potentially increasing the risk of developing Alzheimer's. Understanding these genetic influences is important because they could lead to better ways to diagnose or treat Alzheimer’s disease. Who this helps: This helps researchers and doctors working on Alzheimer’s disease treatments and prevention.

Plain English
This study looked at how nerve damage in the heart differs in patients with idiopathic Parkinson's disease (IPD) compared to healthy individuals. Researchers found that 70% of the 27 patients showed significant heart nerve damage, with an average extent of damage at 62%, while healthy individuals had a much higher nerve density. Understanding this pattern of heart nerve damage is important because it helps in predicting heart health issues in Parkinson's patients, allowing for better management of their condition. Who this helps: This research helps patients with Parkinson's disease and their doctors by providing insights into heart health risks related to their condition.

Plain English
This study looked at brain tissue from 29 patients with multiple system atrophy (MSA) to see if there were signs of TDP-43 or FUS, which are proteins linked to other brain diseases. It found that TDP-43 was rare in these patients, with no evidence of FUS, and these proteins do not seem to contribute to the symptoms of MSA. Instead, the main issues in MSA appear to be caused by a different protein, called alpha-synuclein. Who this helps: This helps patients with MSA and their doctors understand the disease better.

Plain English
This study looked at records from Boston City Hospital between 1930 and 1981 to understand how doctors diagnosed postencephalitic parkinsonism (PEP). Out of 5,270 patient records, only 16 cases were identified as PEP, and for about half of these cases, the diagnosis did not clearly meet established guidelines. These findings indicate that the link between a certain type of brain infection and PEP might not be as strong as previously thought, which could affect how this condition is understood and treated. Who this helps: This helps doctors and researchers interested in accurate diagnoses and treatment for neurological disorders.

Plain English
This study looked at genetic factors linked to late-onset Alzheimer's disease, examining the DNA of many participants across multiple stages. The researchers identified strong associations with specific genes, including MS4A4A and CD33, showing significant links to the disease at levels below 1 in 1 billion. These findings are important because they help us understand genetic risks for Alzheimer's, potentially paving the way for better prevention and treatment options. Who this helps: This research benefits patients and their families, as well as doctors seeking to understand and manage Alzheimer's disease.

Plain English
This study looked at how well clinical evaluations and brain scans (using a technique called positron emission tomography, or PET) agree in identifying different types of mild dementia among 75 participants. They found that only about 65% of the time did the clinical assessments match the imaging results, which means around 35% of the time the two methods disagreed, especially with frontotemporal dementia cases. Improving the accuracy of diagnosing dementia is important as it can help doctors choose the right treatments and better organize future research efforts. Who this helps: This helps patients with dementia and their doctors by refining diagnoses for better treatment options.

Plain English
This study looked at a medication called ELND005, or scyllo-inositol, to see if it is safe and effective for people with mild to moderate Alzheimer's disease. Out of 353 participants, those taking the lowest dose of 250 mg showed some safety and changes in brain markers, but there was no significant improvement in cognitive or daily living tasks compared to those taking a placebo. This research helps identify what the best dose might be for future studies, especially for people diagnosed with Alzheimer's at earlier stages. Who this helps: Patients with Alzheimer's disease and their caregivers.

Plain English
Researchers studied a condition called frontotemporal lobar degeneration (FTLD), a major cause of early-onset dementia, focusing on a specific type linked to a protein called TDP-43. They analyzed genetic data from 515 people with FTLD-TDP and found that certain genetic variations near a gene called TMEM106B significantly increase the risk of developing this condition, with one variation showing a strong link (with a P-value of 1.08 x 10^-11). This discovery could help us understand how FTLD-TDP develops and may lead to better treatments. Who this helps: Patients with frontotemporal lobar degeneration and their families.

Plain English
This study looked at two types of brain scans—one that measures blood flow and another that measures glucose use in the brain—to see how they perform in detecting early signs of dementia and mild cognitive impairment (MCI). The researchers involved 50 people with mild dementia or MCI and compared their results to 80 healthy individuals. They found that both types of scans provided similar information about brain metabolism, but the blood flow scan was slightly less sensitive. This is important because using these scans can help doctors better assess brain function in patients showing early signs of cognitive difficulties. Who this helps: Patients with early dementia and mild cognitive impairment and their doctors.

Plain English
This study examined how certain brain chemicals, specifically cholinergic activity, are affected in patients with Parkinson’s disease (PD), multiple system atrophy (MSA-P), and progressive supranuclear palsy (PSP). Researchers found that while all three conditions showed decreased cholinergic activity compared to healthy individuals, MSA-P and PSP had significantly lower levels in the deeper brain areas, which are linked to balance and movement. In fact, the decreases in these areas were so marked that they could explain why patients with MSA-P and PSP often have more severe balance and walking problems early on compared to those with PD. Who this helps: This helps patients with parkinsonian syndromes and their doctors in understanding their symptoms better.

Plain English
This study looked at the connection between encephalitis lethargica (a brain infection) and postencephalitic parkinsonism (a condition with Parkinson's-like symptoms). It found that the link is more complicated than previously thought, as many diagnoses of encephalitis lethargica were made based on memories rather than clear evidence, and other conditions related to it weren't recognized until later. Understanding this complexity is important because it shows that postencephalitic parkinsonism, like other similar disorders, likely has multiple causes instead of being solely due to encephalitis lethargica. Who this helps: This helps researchers and doctors better understand Parkinson's-like conditions and improve patient care.

Plain English
This study looks at historical records of encephalitis lethargica (EL) and its connection to postencephalitic Parkinsonism (PEP). Researchers found that symptoms of Parkinsonism were not initially linked to EL, and that not all Parkinsonism cases followed an episode of EL. This is important because it challenges the straightforward idea that EL directly causes PEP, suggesting that more research is needed to understand their relationship. Who this helps: This benefits researchers and doctors trying to understand the causes of Parkinsonism in patients.

Plain English
This study looked at the connection between obstructive sleep apnea (a condition that disrupts breathing during sleep) and erectile dysfunction (ED), which is when men have difficulty getting or maintaining an erection. The research found that sleep apnea might affect the body's nerves, hormones, and blood flow, leading to ED. Treating sleep apnea could potentially help improve erectile dysfunction, so doctors should consider screening men with ED for sleep disorders. Who this helps: This helps men with erectile dysfunction and their doctors.

Plain English
This study looked at how moving to the USA affects the chances of developing mood and anxiety disorders, focusing on different immigrant groups based on their country of origin. It found that immigrants from Mexico, Eastern Europe, and Africa or the Caribbean who arrived at age 13 or older had a lower risk of these disorders compared to those born in the US (with odds ranging from 0.34 to 0.49), but those who immigrated before age 13 did not. This is important because it highlights that where someone comes from and when they move can greatly influence their mental health risk in the US. Who this helps: This helps immigrants and mental health professionals understand the risks associated with migration based on age and origin.

Plain English
This document outlines a plan to speed up the search for treatments that can delay or prevent Alzheimer's disease and its symptoms. It highlights important scientific and policy needs that will be included in a larger strategy to address Alzheimer's, which will be presented to Congress and the Obama administration. This is crucial because finding effective treatments can greatly improve the quality of life for those at risk of Alzheimer's and relieve the burden on families and healthcare systems. Who this helps: Patients at risk for Alzheimer's and their families.

Plain English
This study looked at a patient with Wilson's disease (WD) who experienced a rare condition called non-convulsive status epilepticus (SE) after starting a new treatment called Tetrathiomolybdate (TTM). The patient had regular seizures every 5-10 minutes, which were controlled within a day using specific medications. This case is important because it highlights the potential for seizures to occur during different stages and treatments of WD, helping doctors better understand and manage this complication. Who this helps: This helps patients with Wilson's disease and their doctors.

Plain English
This study looked at how to tell apart multiple system atrophy (MSA) from Parkinson's disease (PD), especially in patients with autonomic failure (a condition affecting automatic bodily functions). Researchers found that patients with MSA had significantly worse scores on tests measuring autonomic function, such as a scoring scale (5.9 for MSA vs 3.3 for PD) and a sweat test showing much higher rates of abnormal sweating (57.4% for MSA vs 9.9% for PD). These findings matter because they could help doctors better diagnose diseases, leading to more tailored treatments for patients. Who this helps: This helps patients with MSA and PD, particularly those experiencing autonomic failure.

Plain English
This study tested a drug called bapineuzumab on 234 patients with mild to moderate Alzheimer’s disease to see if it could help with cognitive and functional decline. Although the main results showed no significant improvement in overall cognitive scores, some specific groups, like patients who don’t carry a certain gene (APOE epsilon4), may have shown potential benefits. Some patients experienced temporary brain swelling, but most were not seriously affected, leading researchers to suggest further studies with a focus on those gene carriers. Who this helps: This research is relevant for patients with Alzheimer’s, especially those without the APOE epsilon4 gene, as well as for doctors looking for new treatment options.